Kindred Healthcare, Inc. (NYSE:KND) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Thursday.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Several other research firms have also issued reports on KND. Barclays PLC reiterated a “buy” rating and issued a $13.00 target price (up previously from $11.00) on shares of Kindred Healthcare in a research note on Sunday, May 7th. Mizuho reiterated a “neutral” rating and issued a $9.00 target price on shares of Kindred Healthcare in a research note on Monday, July 3rd. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $10.00 target price on shares of Kindred Healthcare in a research note on Monday, May 15th. Five analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. Kindred Healthcare currently has an average rating of “Hold” and an average price target of $10.00.

Shares of Kindred Healthcare (NYSE:KND) traded up 0.46% on Thursday, reaching $10.90. 539,771 shares of the company’s stock were exchanged. The company’s 50 day moving average is $10.51 and its 200-day moving average is $8.73. Kindred Healthcare has a one year low of $5.65 and a one year high of $12.55. The stock’s market cap is $933.40 million.

Kindred Healthcare (NYSE:KND) last posted its earnings results on Wednesday, May 3rd. The health services provider reported $0.04 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.04. Kindred Healthcare had a positive return on equity of 4.08% and a negative net margin of 9.55%. The company had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.78 billion. On average, analysts anticipate that Kindred Healthcare will post $0.52 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/07/09/kindred-healthcare-inc-knd-downgraded-by-zacks-investment-research.html.

Large investors have recently modified their holdings of the company. Highbridge Capital Management LLC acquired a new stake in shares of Kindred Healthcare during the fourth quarter worth $300,000. Renaissance Technologies LLC raised its stake in shares of Kindred Healthcare by 33.7% in the fourth quarter. Renaissance Technologies LLC now owns 259,280 shares of the health services provider’s stock worth $2,035,000 after buying an additional 65,400 shares during the last quarter. Comerica Bank raised its stake in shares of Kindred Healthcare by 5.5% in the fourth quarter. Comerica Bank now owns 90,575 shares of the health services provider’s stock worth $693,000 after buying an additional 4,686 shares during the last quarter. Oxford Asset Management acquired a new stake in shares of Kindred Healthcare during the first quarter worth $1,722,000. Finally, Point72 Asia Hong Kong Ltd acquired a new stake in shares of Kindred Healthcare during the first quarter worth $121,000. Institutional investors and hedge funds own 89.56% of the company’s stock.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.